The Pleural Disease Program at Penn Medicine offers a unique system that consists of a team of dedicated specialists with a passion and expertise for treating patients with a wide range of pleural disorders, from pleural inflammation to malignant (cancerous) mesothelioma.

Our Pleural Disease Program is home to every treatment option available worldwide and a number of treatments only obtainable at the Harron Lung Center. The program has one goal: to provide you with comprehensive and compassionate care at the highest level possible, both now and in the future, to improve your quality of life with the best pleural disease treatment outcomes.

Our Approach to Pleural Disease Care

The team of physicians who treat pleural diseases are among the best in the world. Their specialties cover thoracic surgery, pulmonary medicine, endocrine and oncologic surgery, hematological oncology, pathology, psychiatry, radiology and radiation oncology.

Your care journey always includes a patient navigator to assist you with any questions and help to schedule your appointments with the pleural disease team.

Choosing Penn Medicine for pleural disease care means choosing dedication to your health. A key aspect of the Pleural Disease Program is the weekly meeting of the multidisciplinary group of specialists who review each case in detail. Following an in-depth discussion of each individual case, your team will develop a personalized treatment plan aimed at optimal results.

Types of Pleural Disease Treated at Penn Medicine

Pleural disease refers to a group of conditions that affect the thin tissue that covers the lungs and lines the chest cavity (pleura) and the fluid-filled space around the lungs (pleural cavity). Each pleural disorder has different causes and symptoms, as well as varying treatment plans depending on your diagnosis.

Penn specialists in the Pleural Disease Program evaluate and treat a wide range of pleural conditions, including:

Promising Results in Clinical Trials for Pleural Disorders

Another important component of the Pleural Disease Program is the easy access to clinical trials focusing on new treatments for pleural disease and mesothelioma. In some cases, Penn is the first and only place in the world to offer certain clinical trials to mesothelioma patients. The use of clinical trials underscores the ultimate goal of our program, which is to offer you the best possible care currently available and to develop the best possible care of the future for mesothelioma and pleural disease patients.

Learn more about other mesothelioma treatments and clinical trials offered through the Mesothelioma Program at the Abramson Cancer Center.

Make an Appointment

Please call 800-789-7366 or make an appointment.

Share This Page: